U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. July 25, 2023: Conversations on Cancer – Cancer Disparities in Appalachia - 07/25/2023
  1. FDA Meetings, Conferences and Workshops

Virtual | Virtual

Event Title
July 25, 2023: Conversations on Cancer – Cancer Disparities in Appalachia
July 25, 2023


Date:
July 25, 2023
Time:
2:30 PM - 4:00 PM ET
Organized By:

Twitter: #ConversationsOnCancer

Sponsored by the U.S. Food & Drug Administration (FDA)

Registration required to attend: https://www.surveymonkey.com/r/NPRCBTR

Background:

Various studies have revealed that where people live affects the disease burden they may face. About 46 million U.S. residents lived in rural areas in 2020 (14% of the U.S. population). A recent study revealed that Appalachia has higher mortality rates than the rest of the nation in seven of the nation's leading causes of death: cancer, heart disease, COPD, injury, stroke, diabetes, and suicide.

Despite advances in cancer prevention and precision cancer care, not all communities have benefited, and cancer disparities persist in the Appalachia community. The Appalachian Region has a cancer mortality rate of 184 per 100,000 population (10% higher than the national rate). Central Appalachia has the highest rate at 222 per 100,000 (32% percent higher than the national rate).

This Conversations on Cancer will focus on the Appalachia community to discuss the factors contributing to the cancer disparities, but also focus on ongoing interventions and opportunities in bridging the cancer chasm in rural health inequity.

Webcast Information:

A free-of-charge webcast of this public panel discussion will be provided. Registration for the webcast is required at the link above.

FDA plans to post archived webcast of this Conversations on Cancer program at: https://www.fda.gov/about-fda/project-community/conversations-cancer

Contact:

For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov

 

 
Back to Top